arrow
Y

Yoke Lim Soong

National Cancer Centre Singapore
H指数:22
被引数:2,520

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tumor immune microenvironment delineates progression trajectories of distinct nasopharyngeal carcinoma phenotypes

肿瘤免疫微环境描绘了不同鼻咽癌表型的进展轨迹

2025-05-230
OA
Plasma Epstein-Barr virus DNA for disease surveillance in endemic nasopharyngeal carcinoma: Analysis of a real-world database

血浆EB病毒DNA在地方性鼻咽癌疾病监测中的应用:真实世界数据库分析

2025-05-010
PRE
Claudin-1 (CLDN1) expression in nasopharyngeal carcinoma (NPC): Association with immune exclusion and implications for immune checkpoint inhibitor (ICI) therapy

Claudin-1 (CLDN1)在鼻咽癌(NPC)中的表达:与免疫排斥的关系及其对免疫检查点抑制剂(ICI)治疗的启示

2024-12-010
PRE
Claudin-1 (CLDN1) tight junction protein expression delineates distinct immune infiltrates in ascending (A) vs descending (D) subtypes of nasopharyngeal carcinoma: Potential implications for treatment selection

Claudin-1 (CLDN1)紧密连接蛋白的表达可区分鼻咽癌升型(A)与降型(D)亚型中不同的免疫浸润:对治疗选择可能存在潜在影响

2024-09-010
PRE
International Recommendations on Reirradiation by Intensity Modulated Radiation Therapy for Locally Recurrent Nasopharyngeal Carcinoma
2021-07-0153
OAAI
Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement
2020-10-015
OAAI
Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement
2020-07-01155
OAAI
International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma
2019-11-01120
OAAI
Intra-patient and inter-patient comparisons of DNA damage response biomarkers in Nasopharynx Cancer (NPC): analysis of NCC0901 randomised controlled trial of induction chemotherapy in locally advanced NPC
2018-11-123
OAAI